After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Ultragenyx Pharmaceutical Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Ultragenyx Pharmaceutical Inc is $3.92B. A total of 0.55 million shares were traded on the day, compared to an average of 913.92K shares.
In the most recent transaction, KAKKIS EMIL D sold 11,727 shares of RARE for 42.23 per share on Dec 30 ’24. After the transaction, the President & CEO now owns 2,183,985 company shares. In a previous transaction on Dec 30 ’24, KAKKIS EMIL D bought 11,727 shares at 42.23 per share.
Among the insiders who sold shares, KAKKIS EMIL D disposed of 8,273 shares on Dec 10 ’24 at a per-share price of $50.00. This resulted in the President & CEO holding 2,195,712 shares of RARE after the transaction. In another insider transaction, KAKKIS EMIL D bought 8,273 shares at $50.00 per share on Dec 10 ’24.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RARE has a high of $60.37 and a low of $37.02.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RARE’s latest balance sheet shows that the firm has $740.20M in Cash & Short Term Investments as of fiscal 2021. There were $41.97M in debt and $181.37M in liabilities at the time. Its Book Value Per Share was $3.76, while its Total Shareholder’s Equity was $922.56M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RARE is Buy with a score of 4.85.
